• USask Science Outreach and VIDO bring vaccine knowledge to Sask schoolkids

    Kids in Northern Saskatchewan and Saskatoon community schools are learning about vaccines straight from the experts through a new University of Saskatchewan (USask) partnership.

  • USask awarded $1.7 million for “high-risk, high-reward” research projects

    Seven innovative new projects from researchers across the University of Saskatchewan (USask) campus have received funding to help make them a reality.

  • Minister Champagne highlights USask’s VIDO in post-budget tour

    The Government of Canada’s commitment to invest in research innovation, talent development and pandemic preparedness was celebrated this morning during Minister of Innovation, Science and Industry François-Philippe Champagne’s visit.

  • USask statement on 2024-25 federal budget

    The University of Saskatchewan applauds the 2024-25 federal budget’s strong support for key areas of post-secondary education and research.

  • USask’s VIDO selected to join DIANA innovation accelerator

    VIDO has been selected to join the North Atlantic Treaty Organization’s (NATO) Defence Innovation Accelerator for the North Atlantic (DIANA) program. VIDO is one of 13 new Canadian test centres chosen to be part of the network.

  • VIDO scientists receive CIHR funding to support research on high impact infectious diseases

    New awards from the Canadian Institutes of Health Research Project Grant from the Fall 2023 competition will support VIDO scientists as they try to solve highly pathogenic coronaviruses, tuberculosis, and influenza.

  • VIDO awarded >$1million to develop innovative solutions for Saskatchewan’s agriculture industry

    Three VIDO scientists were awarded >$1 million in total from the Saskatchewan Ministry of Agriculture’s Agriculture Development Fund (ADF).

  • VIDO awarded U.S. contract for its Vaccine Development Centre

    VIDO has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract by the United States’ National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

  • VIDO’s first Animal Health Summit brings animal health stakeholders together to prepare for foot and mouth disease

    On August 24th, VIDO hosted a half-day summit on foot-and-mouth disease (FMD). Our biannual Animal Health Summit will bring together stakeholders to facilitate knowledge exchange and preparedness on a topic of interest.

  • VIDO and Pirbright expand collaboration to advance vaccine manufacturing

    VIDO has signed a memorandum of understanding (MOU) with the Centre for Veterinary Vaccine Innovation and Manufacturing at the Pirbright Institute in the UK. The MOU allows for expanded animal health collaborations and training.